FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891208565> ?p ?o ?g. }

• W2891208565 endingPage "168" @default.
• W2891208565 startingPage "161" @default.
• W2891208565 abstract "Head and neck squamous cell carcinoma (HNSCC) represent aggressive classes of tumors with a high mortality rate. The mammalian target of rapamycin (mTOR) pathway is instrumental in their initiation and expansion. Although results from pre‐clinical models promise mTOR targeting as a potent novel therapeutic approach, its impact on the tumor microenvironment, such as endothelial cells is only scarcely investigated. Here, we first confirmed the effects of mTOR pharmacological inhibition on cell viability, clonogenicity, and proliferation in HNSCC human cell lines, HN26, and HN30. While Everolimus and Torin1 potently blunted mTOR‐based proliferation of HN26 and HN30 lines, endothelial cells were left intact. To further explore the possibility of a paracrine bystander action of HNSCC‐treated cells on endothelial cells, conditioned medium from Everolimus‐ and Torin1‐challenged HN26 and HN30 cells were collected and applied to naive human endothelial cells. Although endothelial cell viability was again not modified, morphology and mobility were changed. Indeed, spreading of endothelial cells was altered upon challenge with mTOR‐pretreated tumor conditioned‐media, as measured via cell impedance and imagery. Interestingly, this was associated with an augmentation of focal adhesion kinase (FAK) active phosphorylation and enhanced migratory behavior. From a molecular standpoint, the production of vascular endothelial growth factor was elevated in treated HNSCC cells and might contribute to FAK phosphorylation. Although mTOR inhibition in tumor cells did hinder their growth, it also favors the release of factors that subsequently enable endothelial cell migration. Further studies will address how this paracrine action may affect tumor‐driven angiogenesis upon pharmacological treatments." @default.
• W2891208565 created "2018-09-27" @default.
• W2891208565 creator A5027744894 @default.
• W2891208565 creator A5033773140 @default.
• W2891208565 creator A5051554413 @default.
• W2891208565 creator A5059755071 @default.
• W2891208565 creator A5068098786 @default.
• W2891208565 creator A5072024236 @default.
• W2891208565 creator A5078305310 @default.
• W2891208565 date "2018-10-21" @default.
• W2891208565 modified "2023-10-18" @default.
• W2891208565 title "Inhibition of mTOR in head and neck cancer cells alters endothelial cell morphology in a paracrine fashion" @default.
• W2891208565 cites W1970179765 @default.
• W2891208565 cites W1984246346 @default.
• W2891208565 cites W1995012532 @default.
• W2891208565 cites W2021558293 @default.
• W2891208565 cites W2028667039 @default.
• W2891208565 cites W2054917860 @default.
• W2891208565 cites W2063223811 @default.
• W2891208565 cites W2074377887 @default.
• W2891208565 cites W2093797379 @default.
• W2891208565 cites W2111770564 @default.
• W2891208565 cites W2112910897 @default.
• W2891208565 cites W2127429864 @default.
• W2891208565 cites W2156713309 @default.
• W2891208565 cites W2416506714 @default.
• W2891208565 cites W2574677230 @default.
• W2891208565 cites W2588995471 @default.
• W2891208565 cites W2649656222 @default.
• W2891208565 cites W2746718016 @default.
• W2891208565 cites W2789293879 @default.
• W2891208565 cites W2791698913 @default.
• W2891208565 cites W2896869836 @default.
• W2891208565 doi "https://doi.org/10.1002/mc.22911" @default.
• W2891208565 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30230038" @default.
• W2891208565 hasPublicationYear "2018" @default.
• W2891208565 type Work @default.
• W2891208565 sameAs 2891208565 @default.
• W2891208565 citedByCount "4" @default.
• W2891208565 countsByYear W28912085652019 @default.
• W2891208565 countsByYear W28912085652020 @default.
• W2891208565 countsByYear W28912085652021 @default.
• W2891208565 crossrefType "journal-article" @default.
• W2891208565 hasAuthorship W2891208565A5027744894 @default.
• W2891208565 hasAuthorship W2891208565A5033773140 @default.
• W2891208565 hasAuthorship W2891208565A5051554413 @default.
• W2891208565 hasAuthorship W2891208565A5059755071 @default.
• W2891208565 hasAuthorship W2891208565A5068098786 @default.
• W2891208565 hasAuthorship W2891208565A5072024236 @default.
• W2891208565 hasAuthorship W2891208565A5078305310 @default.
• W2891208565 hasBestOaLocation W28912085651 @default.
• W2891208565 hasConcept C121608353 @default.
• W2891208565 hasConcept C123012128 @default.
• W2891208565 hasConcept C151166631 @default.
• W2891208565 hasConcept C170493617 @default.
• W2891208565 hasConcept C202751555 @default.
• W2891208565 hasConcept C2776107976 @default.
• W2891208565 hasConcept C2776530083 @default.
• W2891208565 hasConcept C2776833033 @default.
• W2891208565 hasConcept C2779699572 @default.
• W2891208565 hasConcept C2780394083 @default.
• W2891208565 hasConcept C3020616263 @default.
• W2891208565 hasConcept C43060935 @default.
• W2891208565 hasConcept C502942594 @default.
• W2891208565 hasConcept C54355233 @default.
• W2891208565 hasConcept C55493867 @default.
• W2891208565 hasConcept C62478195 @default.
• W2891208565 hasConcept C7876069 @default.
• W2891208565 hasConcept C86554907 @default.
• W2891208565 hasConcept C86803240 @default.
• W2891208565 hasConcept C95444343 @default.
• W2891208565 hasConceptScore W2891208565C121608353 @default.
• W2891208565 hasConceptScore W2891208565C123012128 @default.
• W2891208565 hasConceptScore W2891208565C151166631 @default.
• W2891208565 hasConceptScore W2891208565C170493617 @default.
• W2891208565 hasConceptScore W2891208565C202751555 @default.
• W2891208565 hasConceptScore W2891208565C2776107976 @default.
• W2891208565 hasConceptScore W2891208565C2776530083 @default.
• W2891208565 hasConceptScore W2891208565C2776833033 @default.
• W2891208565 hasConceptScore W2891208565C2779699572 @default.
• W2891208565 hasConceptScore W2891208565C2780394083 @default.
• W2891208565 hasConceptScore W2891208565C3020616263 @default.
• W2891208565 hasConceptScore W2891208565C43060935 @default.
• W2891208565 hasConceptScore W2891208565C502942594 @default.
• W2891208565 hasConceptScore W2891208565C54355233 @default.
• W2891208565 hasConceptScore W2891208565C55493867 @default.
• W2891208565 hasConceptScore W2891208565C62478195 @default.
• W2891208565 hasConceptScore W2891208565C7876069 @default.
• W2891208565 hasConceptScore W2891208565C86554907 @default.
• W2891208565 hasConceptScore W2891208565C86803240 @default.
• W2891208565 hasConceptScore W2891208565C95444343 @default.
• W2891208565 hasFunder F4320321589 @default.
• W2891208565 hasFunder F4320322361 @default.
• W2891208565 hasFunder F4320322646 @default.
• W2891208565 hasIssue "1" @default.
• W2891208565 hasLocation W28912085651 @default.
• W2891208565 hasLocation W28912085652 @default.
• W2891208565 hasOpenAccess W2891208565 @default.

• next